Research Article

Dynamic Modeling of the Angiogenic Switch and Its Inhibition by Bevacizumab

Table 3

Simulated and measured average total volumes on day 21 ().

Therapy

No therapy 1.03 No data
Therapy 1 6.67 6.60
Therapy 2 3.99 3.26